Skip to main content
SpringerLink
Log in

Adalimumab

Allergy, dermatitis and decreased drug efficacy: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Paltiel M, Gober LM, Deng A, Mikdashi J, Alexeeva I, Saini SS, Gaspari AA.Immediate type I hypersensitivity response implicated in worsening injection site reactions to adalimumab. Archives of Dermatology 144: 1190-1194, No. 9, Sep 2008 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adalimumab. React. Wkly. 1221, 6–7 (2008). https://doi.org/10.2165/00128415-200812210-00016

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812210-00016

Keywords

Search

Navigation